Tag: Biomics LLC

AUSTIN, Texas, Sept. 13, 2022 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce that it will be attending and its founder, Christian Drapeau, will be speaking at the upcoming 8th Annual Biohacking Conference. The conference, which is completely sold out, will be held September 15-17 at The Beverly Hilton in Beverly Hills, California.

AUSTIN, Texas, April 29, 2022 (SEND2PRESS NEWSWIRE) -- Kalyagen® is pleased to announce that it will be attending the Fort Lauderdale Open as part of its sponsorship of golf professional Jerrel Gill. The Open will be hosted at the Fort Lauderdale Country Club on May 2-3, 2022.

AUSTIN, Texas, April 27, 2022 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce that it will be attending and hosting a booth (#121) at the upcoming Paleo f(x)™ 2022 conference to be held in Austin on April 29 - May 1. STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

AUSTIN, Texas, March 10, 2022 (SEND2PRESS NEWSWIRE) -- Kalyagen® is pleased to announce that it is a supporting partner of two upcoming South Florida PGA Section events and golf professional Jerrel Gill. The two events are the South Florida PGA Foundation PGA HOPE Classic on May 12, 2022 and the South Florida Open on June 21-23, 2022.

AUSTIN, Texas, March 4, 2022 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce that it will be attending and hosting a booth (#215) at the upcoming South by Southwest® (SXSW®) Wellness Expo. The Wellness Expo is open to all SXSW Badges and is free and open to the public from March 12-13, 2022 from 11 a.m. - 5 p.m. at the Palmer Events Center in Exhibit Halls 1 & 2.

AUSTIN, Texas, Oct. 12, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce the successful product registration of STEMREGEN® in Spain. This announcement coincides with Christian Drapeau's, CEO and Chief Scientist of Kalyagen, trip to Madrid, Spain last week to speak at the IV Jornadas Internacionales Otto H. Warburg symposium at the NH Madrid Príncipe de Vergara.

AUSTIN, Texas, July 14, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen® has announced the release and availability of a free eBook, "The Stemregen Effect - Tapping into the Power of Your Own Stem Cells," which provides an overview of how stem cells are the body's repair system and how STEMREGEN®, a natural stem cell enhancer, has been documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

AUSTIN and FORT WORTH, Texas, June 15, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen® and Uniwell Laboratories announced today that they have entered into a joint venture to produce the unique, patent-pending Juviqa Stem Cell Beauty System and expand Uniwell's manufacturing capabilities to include cosmetics.

AUSTIN, Texas, May 13, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™ is pleased to announce that the next part of "The Stemregen Effect" digital media campaign will be filmed in Belize and feature actor, comedian, writer and producer Chris Spencer to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

AUSTIN, Texas, April 3, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™ is pleased to announce the release of its "The Stemregen Effect" social media ad featuring former UCLA Bruins and NBA players Niguel Miguel, Marques Johnson and Mitchell Butler to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

AUSTIN, Texas, Feb. 8, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen is pleased to announce the launch of its "Stem the Tide of Time" social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM). (VIDEO)

AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.